Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2011.01.11
中国建银投资证券有限责任公司关于《深圳市大地妈妈药业股份有限公司关于公司专项治理的自...
2011.01.11
独立董事候选人声明（解冻）
2011.01.11
第一届董事会第二十三次会议决议公告
2011.01.11
第一届监事会第十二次会议决议公告
2011.01.11
独立董事候选人声明（周海梦）
2011.01.11
独立董事候选人声明（徐滨）
2011.01.11
关于选举职工代表担任监事的职工代表大会决议公告
2010.12.21
关于监事会换届选举的提示性公告
2010.12.21
关于董事会换届选举的提示性公告
2010.12.09
关于投资设立成都市海通药业有限公司进展的公告
第一页
上一页
149
150
151
152
153
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
